Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors

European Journal of Gastroenterology and Hepatology - Tập 25 Số 2 - Trang 232-238 - 2013
Maxime Palazzo1,2,3,4,5, Catherine Lombard‐Bohas6, Guillaume Cadiot7, Tamara Matysiak‐Budnik8, Vinciane Rebours1,2, Marie‐Pierre Vullierme1,9,2, Anne Couvelard10,2, Olivia Hentic1,2, Philippe Ruszniewski1,2
1Department of Gastroenterology-Pancreatology, Beaujon Hospital, Clichy
2Paris 7-Denis Diderot University
3e-mail: [email protected]
4fax: +33 142 703 784
5to Maxime Palazzo, Department of Gastroenterology-Pancreatology, Beaujon Hospital, 100, boulevard du Général Leclerc, F-92118 Clichy, Cedex, Paris, France Tel: +33 140 875 255
6Department of Medical Oncology, Edouard Herriot Hospital, Lyon
7Department of Hepato-gastroenterology, Robert Debre Hospital and Reims University, Reims
8Department of Gastroenterology, Hôtel-Dieu Hospital and Nantes University, Nantes, France
9Department of Radiology, Beaujon Hospital, Clichy
10Department of Pathology, Bichat Hospital, Paris

Tóm tắt

Từ khóa


Tài liệu tham khảo

Yao, 2008, J Clin Oncol, 26, 3063, 10.1200/JCO.2007.15.4377

Lepage, 2007, Gastroenterology, 132, 899, 10.1053/j.gastro.2007.01.006

Modlin, 1997, Cancer, 79, 813, 10.1002/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2

Ohrvall, 2000, World J Surg, 24, 1402, 10.1007/s002680010232

Nave, 2001, Surgery, 129, 170, 10.1067/msy.2001.110426

Hellman, 2002, World J Surg, 26, 991, 10.1007/s00268-002-6630-z

Sarmiento, 2003, J Am Coll Surg, 197, 29, 10.1016/S1072-7515(03)00230-8

King, 2008, Cancer, 113, 921, 10.1002/cncr.23685

Eriksson, 1998, Cancer, 83, 2293, 10.1002/(SICI)1097-0142(19981201)83:11<2293::AID-CNCR8>3.0.CO;2-E

Gupta, 2005, Cancer, 104, 1590, 10.1002/cncr.21389

Ruszniewski, 1993, Cancer, 71, 2624, 10.1002/1097-0142(19930415)71:8<2624::AID-CNCR2820710830>3.0.CO;2-B

Eriksson, 2008, World J Surg, 32, 930, 10.1007/s00268-008-9510-3

Cao, 2010, Br J Surg, 97, 537, 10.1002/bjs.6931

Moertel, 1992, N Engl J Med, 326, 519, 10.1056/NEJM199202203260804

Kouvaraki, 2004, J Clin Oncol, 22, 4762, 10.1200/JCO.2004.04.024

Jacobsen, 1995, Scand J Gastroenterol, 30, 789, 10.3109/00365529509096329

Yao, 2008, J Clin Oncol, 26, 1316, 10.1200/JCO.2007.13.6374

Yao, 2011, N Engl J Med, 364, 514, 10.1056/NEJMoa1009290

Raymond, 2011, N Engl J Med, 364, 501, 10.1056/NEJMoa1003825

Kwekkeboom, 2008, J Clin Oncol, 26, 2124, 10.1200/JCO.2007.15.2553

Oberg, 2004, Ann Oncol, 15, 966, 10.1093/annonc/mdh216

Strosberg, 2010, World J Gastroenterol, 16, 2963, 10.3748/wjg.v16.i24.2963

Wymenga, 1999, J Clin Oncol, 17, 1111, 10.1200/JCO.1999.17.4.1111

Arnold, 1992, Metabolism, 41, 116, 10.1016/0026-0495(92)90044-B

Saltz, 1993, Cancer, 72, 244, 10.1002/1097-0142(19930701)72:1<244::AID-CNCR2820720143>3.0.CO;2-Q

Ducreux, 2000, Am J Gastroenterol, 95, 3276, 10.1111/j.1572-0241.2000.03210.x

Rinke, 2009, J Clin Oncol, 27, 4656, 10.1200/JCO.2009.22.8510

Eisenhauer, 2009, Eur J Cancer, 45, 228, 10.1016/j.ejca.2008.10.026

Arnold, 2008, Clin Gastroenterol Hepatol, 6, 820, 10.1016/j.cgh.2008.02.052

Butturini, 2006, Endocr Relat Cancer, 13, 1213, 10.1677/erc.1.01200

Aparicio, 2001, Eur J Cancer, 37, 1014, 10.1016/S0959-8049(01)00073-9

Shojamanesh, 2002, Cancer, 94, 331, 10.1002/cncr.10195

Faiss, 2003, J Clin Oncol, 21, 2689, 10.1200/JCO.2003.12.142

Panzuto, 2005, Endocr Relat Cancer, 12, 1083, 10.1677/erc.1.01017

Dromain, 2005, J Clin Oncol, 23, 70, 10.1200/JCO.2005.01.013

Scigliano, 2009, Endocr Relat Cancer, 16, 977, 10.1677/ERC-08-0247

Elias, 2010, Ann Surg, 251, 307, 10.1097/SLA.0b013e3181bdf8cf